Breaking News
0
Ad-Free Version. Subscribe now to follow markets, faster and distraction-free. More details
Close

Uniqure NV (QURE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Uniqure NV's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
32.95 -1.80    -5.18%
04/03 - Closed. Currency in USD ( Disclaimer )
After Hours
33.00
+0.05
+0.15%
0:34:03 - Real-time Data
Type:  Equity
Market:  United States
ISIN:  NL0010696654 
CUSIP:  001069665
  • Volume: 678,325
  • Bid/Ask: 32.60 / 35.97
  • Day's Range: 32.72 - 35.50
Uniqure NV 32.95 -1.80 -5.18%
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close34.75
Day's Range32.72 - 35.5
Revenue6.04M
Open34.54
52 wk Range32.78 - 71.45
EPS - 2.82
Volume678,325
Market Cap1.48B
Dividend (Yield)N/A (N/A)
Average Volume (3m)549,291
P/E RatioN/A
Beta1.37
1-Year Change - 38.56%
Shares Outstanding44,993,987
Next Earnings DateMay 03, 2021
What is your sentiment on Uniqure NV?
or
Market is currently closed. Voting is open during market hours.

Uniqure NV News


Technical Summary

Type 5 Min 15 Min Hourly Daily Monthly
Moving Averages Strong Sell Strong Sell Strong Sell Strong Sell Sell
Technical Indicators Strong Sell Strong Sell Strong Sell Strong Sell Strong Sell
Summary Strong Sell Strong Sell Strong Sell Strong Sell Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Inverted Hammer 30 Current
Three Black Crows 1D Current
Completed Patterns
Engulfing Bearish 1D 2 Mar 02, 2021
Engulfing Bearish 1M 3 Dec 20
Three Black Crows 15 3 Mar 04, 2021 21:00

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  MTN Nigeria 162.00 162.00 162.00 -8.00 -4.71% 599.06K 04/03  
  FBN Holdings 7.05 7.10 6.75 -0.05 -0.70% 31.25M 04/03  
  Guaranty Trust Bank 31.50 31.80 31.05 -0.20 -0.63% 15.50M 04/03  
  Zenith Bank 25.30 25.65 25.30 -0.25 -0.98% 38.65M 04/03  
  UBA 7.95 8.15 7.75 -0.30 -3.64% 26.78M 04/03  
  ETI 5.00 5.00 5.00 -0.20 -3.85% 2.15M 04/03  
  Forte Oil Plc 14.65 14.65 14.65 -1.60 -9.85% 1.07M 04/03  
  Nestle Nigeria 1,350.00 1,350.00 1,350.00 0.00 0.00% 71.83K 04/03  
  Nem 1.730 1.720 1.720 -0.190 -9.95% 471.84K 04/03  
  Wema Bank 0.60 0.62 0.60 -0.04 -6.15% 1.63M 04/03  

Uniqure NV Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

248

Equity Type

ORD

Uniqure NV is a company based in the Netherlands specialized in gene therapy. It seeks to develop one-time administered treatments with potentially curative results for patients suffering from genetic and other devastating diseases. It develops, both internally and through partnerships, a pipeline of gene therapies. It produces adeno-associated virus based, or AAV-based, gene therapies in its own facilities with a proprietary, commercial-scale, current good manufacturing practices, compliant, manufacturing process. AMT-061, the Company’s lead product candidate for patients with hemophilia B, is going through a dosing phase of a pivotal study. AMT-130, the product candidate for patients with Huntington’s disease is in Phase I/II clinical study.

Read More
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

QURE Comments

Write your thoughts about Uniqure NV
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email